CNS Clinical Trials

CNS Clinical Trials

Suicidality and Data Collection: Workshop Summary

  • Author: Altevogt, Bruce; Davis, Miriam; Hanson, Sarah
  • Publisher: National Academies Press
  • ISBN: 9780309148832
  • eISBN Pdf: 9780309148849
  • eISBN Epub: 9780309186483
  • Place of publication:  United States
  • Year of digital publication: 2010
  • Month: December
  • Pages: 89
  • Language: English

The Food and Drug Administration (FDA) now requires that all clinical trials for drugs that affect the central nervous system—including psychiatric drugs—are assessed for whether that drug might cause suicidal ideation or behavior. The Institute of Medicine's (IOM) Forum on Neuroscience and Nervous System Disorders hosted a meeting on June 26, 2009, to discuss the FDA's new policy and how to analyze best whether suicidal thoughts predict actual suicidal behavior in the near future.

  • FrontMatter
  • Reviewers
  • Contents
  • Introduction
  • 1 Perspectives from the FDA, Academia, and Patients
  • 2 Data Collection and Optimization
  • 3 Data Analysis
  • 4 Partnerships, Opportunities, Collaboration
  • Appendix A: References
  • Appendix B: Workshop Agenda
  • Appendix C: Workshop Attendees
  • Appendix D: Biographical Sketches of Invited Speakers

Subjects

SUBSCRIBE TO OUR NEWSLETTER

By subscribing, you accept our Privacy Policy